National and Kapodistrian University of Athens
Μελέτη του ομοδιμερισμού της πρωτεΐνης bri2
Abstract
dc:descriptionBRI2 is a protein involved in Familial British Dementia (FBD) and Familial Danish Dementia (FDD), since patients with those dementias bear mutations in the gene that encodes for BRI2. Both diseases are characterized by progressive dementia and result in death. FBD and FDD present striking neuropathological similarities with Alzhemer’s disease (AD). Among those similarities is the deposition of amyloid peptides in the brains of patients. In FBD/FDD the peptides are produced after the proteolytic processing of the mutated forms of BRI2. In AD the peptide deposited is Aβ, and is derived from the proteolytic processing of the Amyloid Precursor Protein (APP). BRI2 physiological role remains elusive. Ηowever, there are studies that attribute different functions to BRI2. For example, we showed previously that BRI2 interacts with APP and reduces its proteolysis, as well as Aβ production. In an attempt to approach the physiological role of BRI2, we examined the possibility that it homodimerizes. Two structural features in the primary structure of BRI2 led us to hypothesize that it could homodimerize. First, BRI2 contains in its transmembrane domain the GXXXG motif that has been implicated in the homodimerization of transmembrane proteins. In addition, BRI2 contains in its extracellular sequence one free cysteine residue 89 (C89) that could mediate the association of two BRI2 molecules through an intermolecular disulfide bond. Based on the above, we showed that in cell lines expressing two BRI2 proteins tagged with different epitope tags, two BRI2 molecules interact. In addition, we directly detected the homodimers in cells using the BiFC assay (Bimolecular Fluorescence Complementation). Endogenous BRI2 in mouse brain extracts also forms homodimers. Subsequently, the involvement of the GXXXG motif in BRI2 homodimerization was examined. Mutation of glycine to leucine residues, and immunoprecipitation experiments, indicated that mutation of the motif does not inhibit homodimerization. To investigate whether BRI2 homodimerizes with the involvement of disulfide bonds, we expressed BRI2 in cells and performed Western Blot analysis of the cell extracts under non-reducing conditions. Under these conditions, we detected monomers as well as homodimers in double the molecular weight of the monomer. Mutation of cysteine indicated that it is responsible for the formation of the intermolecular disulfide bonds formed between two BRI2 molecules. Apart from disulfide bonds non-covalent interactions were shown to participate in the homodimerization. To identify the responsible region for those interactions we created BRI2 constructs that bear certain deletions and a mutation in C89. Using the corresponding mutated proteins we showed that non-covalent interactions exist within the sequence after aminoacid 107. In addition, we showed that BRI2 homodimers are formed in the ER and that BRI2 exists at the cell surface as a homodimer. Finally, we showed that homodimerization is a prerequisite for BRI2 interaction with APP.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Τσαχάκη, Μαρία
- Tsachaki, Maria
Subjects
dc:subject × 20Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/18808